This study tests whether taking low-dose aspirin daily can help prevent colorectal cancer from returning in patients whose tumors have certain gene mutations (PI3K pathway). The trial includes 626 people with stage II or III colon or rectal cancer who have had surgery. Researcher…
Phase: PHASE3 • Sponsor: Anna Martling • Aim: Disease control
Last updated May 08, 2026 12:02 UTC